Skip to main content
SpringerLink
Log in

Mechanisms of Interferon Action and Resistance in Chronic Hepatitis C Virus Infection: Lessons Learned from Cell Culture Studies

  • Chapter
Hepatitis C Virus Disease

  • 671 Accesses

Abstract

Alpha interferon, usually in combination with ribavirin, is currently the standard care for patients infected with hepatitis C virus. Unfortunately, a significant number of patients fail to eradicate their infection with this regimen. The molecular details concerning the failure of many patients to achieve sustained clearance of the virus infection after interferon therapy are currently unknown. The primary focus of this chapter is to provide an overview of interferon action and resistance against hepatitis C virus (HCV) based on our understanding developed from in vitro experiments. Interferon first binds to receptors on the cell surface; this initiates a cascade of signal transduction pathways leading to the activation of antiviral genes. Using a cell culture model, we determined that the activation of an interferon promoter (interferon inducible genes) is important for a successful antiviral response against HCV. The level of activation of the IFN promoter by exogenous interferon appears to vary among different replicon cell lines. It was observed that a replicon cell line showing low activation of the IFN promoter frequently develops resistant phenotypes compared to cell lines with higher activation. Furthermore, interferon-alpha, -beta, and -gamma are each found to inhibit replication of HCV in the cell culture. The antiviral action of interferon is targeted to the highly conserved 5’ untranslated region (5’ UTR) utilized by the virus to translate protein by an internal ribosome entry site (IRES) mechanism. This effect is the same among HCVs of other genotypes. Interferon inhibits translation of HCV by blocking at the level of formation of polyribosomes on the IRES containing mRNA. These in vitro studies suggest that differences in the regulation of IRES-mediated translation by interferon among hepatic cell clones may be directly related to the development of interferon resistance in chronic HCV infection.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Akira, S., Uematsu, S., Takeucji, O. (2006). Pathogen recognition and innate immunity. Cell, 124: 783–801.

    Article  PubMed  CAS  Google Scholar 

  • Bach, E.A., Aguet, M., Schreiber, R.D. (1997). The IFN gamma receptor: a paradigm for cytokine receptor signaling. Annual Review of Immunology, 15: 571–591.

    Article  Google Scholar 

  • Basu, A., Meyer, K., Ray, R.B., Ray, R. (2001). Hepatitis C virus core protein modulates the interferon-induced transacting factors of JAK/STAT signaling pathways but does not affect the activation of downstream IRF-1 or 561 gene. Virology, 288: 379–390.

    Article  PubMed  CAS  Google Scholar 

  • Bekisz, J., Schmeisser, H., Hernandez, J., Goldman, N.D., Zoon, K.C. (2004). Human interferons alpha, beta and omega. Growth Factors, 22: 243–251.

    Article  PubMed  CAS  Google Scholar 

  • Blindenbacher, A., Duong, F.H.T., Hunziker, L., Stutvoet, S.T.D., Wang, X., Terracciano, L., Moradpour, D., Blum, H.E., Alonzi, T., Tripodi, M., Monika, N.L., Heim, M.H. (2003). Expression of hepatitis C virus proteins inhibits interferon alfa signaling in the liver of transgenic mice. Gastroenterology, 124: 1465–1475.

    Article  PubMed  CAS  Google Scholar 

  • Blatt, L.M., Davis, J.M., Klein, S.B., Taylor, M.W. (1996). The biological activity and molecular characterization of a novel synthetic interferon alpha species, consensus interferon. Journal of Interferon and Cytokine Research, 16: 489–499.

    PubMed  CAS  Google Scholar 

  • Bosch, F.X., Ribes, J., Diaz, M., Cleries, R. (2004). Primary liver cancer: worldwide incidence and trends. Gastroenterology, 127: S5–S16.

    Article  PubMed  Google Scholar 

  • Cheney, I.W., Lai, V.C.H., Zhong, W., Brodhag, T., Dempsey, S., Lim, C., Hong, Z., Lau, J.Y.N., Tam, R.C. (2002). Comparative analysis of anti-hepatitis C virus activity and gene expression mediated by alpha, beta, and gamma interferons. Journal of Virolology, 76: 11148–11154.

    Article  CAS  Google Scholar 

  • Choo, Q.L., Kuo, G., Weiner, A.J., Overby, L.R., Bradley, D.W., Houghton, M. (1989). Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science, 244: 359–362.

    Article  PubMed  CAS  Google Scholar 

  • Chung, R.T., He, W., Saquib, A., Contreras, A.M., Xavier, R.J., Chawla, A., Wang, T.C., Schmidt, E.V. (2001). Hepatitis C virus replication is directly inhibited by IFN-alfa in a full-length binary expression system. Proceedings of National Academy of Sciences (USA), 98: 9847–9852.

    Google Scholar 

  • Colamonici, O.R., Uyttendale, H., Domanski, P., Yan, H., Krolewski, J.J. (1994). P135 tyk2 an interferon-dependent tyrosine kinase, is physically associated with an interferon receptor. Journal of Biological Chemistry, 269: 3518–3522.

    PubMed  CAS  Google Scholar 

  • Darnell, J.E. Jr. (1998). Studies of interferon–induced transcriptional activation uncover the Jak–STAT pathway. Journal of Interferon and Cytokines, 18: 549–554.

    CAS  Google Scholar 

  • Dash, S., Hiramatsu, N., Gerber M.A. (1997). Transfection of HepG2 cells with infectious hepatitis C virus RNA genome. American Journal of Pathology, 151: 363–373.

    PubMed  CAS  Google Scholar 

  • Dash, S., Kalkeri, G., McClure, H.M., Garry, R.F., Clejan, S., Thung, S.N., Murthy, K.K. (2001). Transmission of HCV to a chimpanzee using virus particles produced in an RNA transfected hepG2 cell culture. Journal of Medical Virology, 65: 276–281.

    Article  PubMed  CAS  Google Scholar 

  • Dash, S., Prabhu, R., Hazari, S., Bastian, F., Garry, R.F., Zou, W., Haque, S., Joshi V., Regenstein, F.G., Thung S.N. (2005). Interferons alpha, beta, gamma each inhibits hepatitis C virus replication at the level internal ribosome entry site mediated translation. Liver International, 25: 1–15.

    Article  CAS  Google Scholar 

  • Davis, G., Lau, J. (1997). Factors predictive of a beneficial response to therapy of hepatitis C. Hepatology, 26 (suppl. 1): 122S–127S.

    Google Scholar 

  • Davis, G.L., Esteban-Mur, R., Rustgi, V., Hoef, J., Gordon, S.C., Trepo, C., Shiffman, M.L., Zeuzem, S., Craxi, A., Ling, M.H., Albrecht, J. (1998). Interferon alpha-2b alone or in combination with ribavirin for the treatment of relapse of chronic hepatitis C. International Hepatitis International therapy group. New England Journal of Medicine, 339: 1493–1499.

    Article  PubMed  CAS  Google Scholar 

  • Diaz, M.O., Pomykala, H.M., Bohlander, S.K., Maltepe, E., Malik, K., Brownstein, B. Olopade, O.I. (1994). Structure of the human type 1 interferon gene cluster determined from a YAC clone. Genomics, 22: 540–542.

    Article  PubMed  CAS  Google Scholar 

  • Domanski, P., Colamonici, O.R. (1996). The type-1 interferon receptor. The long and short of it. Cytokine Growth Factor Review, 7: 143–151.

    Google Scholar 

  • Domanski, P., Witte, M., Kellum, M., Runinstein, M., Hackett, R., Pitha, P., Colamonici O.R. (1995). Cloning and expression of a long form of beta subunit of the interferon alpha/beta receptor that is required for signaling. Journal of Biological Chemistry, 270: 21606–21611.

    Article  PubMed  CAS  Google Scholar 

  • El-Serag, H.B. (2004). Hepatocellular carcinoma: recent trends in the United States. Gastroenterology, 127: S27–34.

    Article  PubMed  Google Scholar 

  • Enomoto, N., Sakuma, I., Asahina, Y., Kurosaki, M., Murakami, T., Yamamoto, C., Izumi, N., Marumo, F., Sato, C. (1995). Comparison of full-length sequences of interferon-sensitive and resistant hepatitis C virus 1b. Journal of Clinical Investigation, 96: 224–230.

    PubMed  CAS  Google Scholar 

  • Enomoto, N., Sakuma, I., Asahina, Y., Kurasaki, M., Murakami, T., Yamamoto, C., Ogura, Y., Izumi, N., Murumo, F., Sato, C. (1996). Mutation in the nonstructural protein 5A gene and response to interferon in patients with chronic hepatitis C virus 1b infection. New England Journal of Medicine, 334: 77–81.

    Article  PubMed  CAS  Google Scholar 

  • Feld, J.J., Hoofnagle, J.H. (2005). Mechanism of action of interferon and ribavirin treatment of hepatitis C. Nature, 436: 967–972.

    Article  PubMed  CAS  Google Scholar 

  • Fenteany, G., Schreiber, S.L. (1998). Lactacystin, proteasome function and cell fate. Journal of Biological Chemistry, 273: 8545–8548.

    Article  PubMed  CAS  Google Scholar 

  • Ferreon, J.C., Ferreon, A.C.M., Li, K., Lemon, S.M. (2005). Molecular determinants of TRIF proteolysis mediated by the hepatitis C virus NS3/4A protease. Journal of Biological Chemistry, 280: 20483–20492.

    Article  PubMed  CAS  Google Scholar 

  • Francki, R.I.B., Fauquet, C.M., Knudson, D.L., Brown, F. (1991). Classification and nomenclature of viruses: fifth report of the international committee on taxonomy of viruses. Archives Virology (Suppl. 2), 223.

    Google Scholar 

  • Francois, C., Duverlie, G., Rebouillat, D., Khorsi, H., Castelain, S., Blum, H.E., Gatignol, A., Wychowski, C., Moradpour, D., Meurs, E.F. (2000). Expression of hepatitis C virus proteins interferes with the antiviral action of interferon independently of PKR-mediated control of protein synthesis. Journal of Virology, 74: 5587–5596.

    Article  PubMed  CAS  Google Scholar 

  • Frese, M., Schwarzle, V., Barth, K., Krieger N., Lohmann V., Mihm S., Haller O., Bartenschalager R. (2002). Interferon gamma inhibits replication of subgenomic and genomic hepatitis C virus RNAs. Hepatology, 35: 694–703.

    Article  PubMed  CAS  Google Scholar 

  • Friebe, P., Bartenschlager, R. (2002). Genetic analysis of sequences in the 3’ nontranslated region of hepatitis C virus that are important for RNA replication. Journal of Virology, 76: 5326–5338.

    Article  PubMed  CAS  Google Scholar 

  • Friebe, P., Lohmann, V., Krieger, N., Bartenschalager, R. (2001). Sequences in the 5‘UTR nontranslated region of hepatitis C virus required for RNA replication. Journal of Virology, 75: 12047–12057.

    Article  PubMed  CAS  Google Scholar 

  • Foy, E., Li, K., Wang, C., Sumpter, R., Ikeda, M., Lemon, S.M., Gale, M. (2003). Regulation of interferon regulatory factor-3 by the hepatitis C virus serine protease. Science, 300: 1145–1148.

    Article  PubMed  CAS  Google Scholar 

  • Foy, E., Li, K., Sumpter, R., Loo, Y.-M., Johnson, C.L., Wang, C., Fish, P.M., Yoneyama, M., Fujita, T., Lemon, S.M., Gale, M. (2005). Control of antiviral defense through hepatitis C virus disruption of retinoic acid-inducible gene-1 signaling. Proceedings of National Academy of Sciences, 102: 2986–2991.

    Article  CAS  Google Scholar 

  • Fried, M.W., Shiffman, M.L., Reddy, K.R., Smith, C., Marinos, G., Goncales, F.L. Jr, Haussinger, D., Diago, M., Carosi, G., Dhumeaux, D., Craxi A., Lin, A., Hoffman, J., Yu, J. (2002). Peginterferon alpha-2b plus ribavirin for chronic hepatitis C virus infection. New England Journal of Medicine, 347: 975–982.

    Article  PubMed  CAS  Google Scholar 

  • Gale, M., Korth, M.J., Tang, N.M., Tan, S.L., Hopkins, D.A., Dever, T.E., Polyak, S.J., Gretch, D.R., Katze, M.G. (1997). Evidence that hepatitis C virus resistance to interferon is mediated through repression of the PKR protein kinase by the nonstructural 5A protein. Virology, 230: 217–227.

    Article  PubMed  CAS  Google Scholar 

  • Gale, M., Blakely, C.M., Kwieciszewski, B., Tan, S.-L., Dossett, M., Tang, N.M., Korth, M.J., Polyak, S.J., Gretch, D.R., Katze, M.G. (1998). Control of PKR protein kinase by hepatitis C virus non-structural 5A protein: molecular mechanisms of kinase regulation. Molecular and Cellular Biology, 18: 5208–5218.

    PubMed  CAS  Google Scholar 

  • Garcia-Sastre, A., Biron, C.A. (2006). Type 1 interferons and the virus-host relationship: a lesson in dètente. Science , 312: 879–882.

    Article  PubMed  CAS  Google Scholar 

  • Goodbourn, S., Didcock, L., Randall, R.E. (2000). Interferons: cell signaling, immune modulation, antiviral responses and virus countermeasures. Journal of General Virology, 81: 2341–2364.

    PubMed  CAS  Google Scholar 

  • Guo, J., Bichko, V.V., Seeger, C. (2001). Effect of alpha interferon on the hepatitis C virus replicon. Journal of Virology, 75: 8516–8523.

    Article  PubMed  CAS  Google Scholar 

  • Guo, J., Zhu, Q., Seeger, C. (2003). Cytopathic and noncytopathic interferon responses in cells expressing hepatitis C virus subgenomic replicons. Journal of Virology, 77: 10769–10779.

    Article  PubMed  CAS  Google Scholar 

  • Guo, J., Sohn, J.A., Zhu, Q., Seeger, C. (2004). Mechanism of the interferon alpha response against hepatitis C virus replicons. Virology, 325: 71–81.

    Article  PubMed  CAS  Google Scholar 

  • Hadziyannis, S.J., Sette, H. Jr., Morgan, T.R., Balan, V., Diago, M., Marcellin, P., Ramadori G., Bodenheimer H. Jr., Bernstein, D., Rizzetto, M., Zeuzem, S., Pockros, P.J., Lin, A., Ackrill, A.M., PEGASYS International Study Group. (2004). Peginterferon-alpha2a and ribavirin combination therapy in chronic hepatitis C. A randomized study of treatment duration and ribavirin dose. Annals of Internal Medicine, 140: 346–355.

    Google Scholar 

  • Hazari, S., Bastian, F.O., Garry, R.F., Dash, S. (2004). Translational regulation of HCV-IRES mRNA in interferon treated Huh-7 cells. Hepatology, A-619, P-433A.

    Google Scholar 

  • Hazari, S., Taylor, L., Garry, R.F., Loftig, R., Dash, S. (2005a). Lower activation of ISRE promoter among cell clones replicating HCV sub-genomic RNA leads to interferon resistance. Hepatology, 42: P-247A, A: 128.

    Google Scholar 

  • Hazari, S., Patil, A., Joshi, V., Sullivan, D.E., Fermin, C.D., Garry, R.F., Elliott, R.M., Dash, S. (2005b). Alpha interferon inhibits translation mediated by the internal ribosome entry site of six different hepatitis C virus genotypes. Journal of General Virology, 86: 3047–3053.

    Google Scholar 

  • He, Y., Yan, W., Coito, C., Li, Y., Gale, M. Jr., Katze, M.G. (2003). The regulation of hepatitis C virus (HCV) internal ribosome-entry site-mediated translation by HCV replicons and nonstructural proteins. Journal of General Virology, 84: 535–543.

    Article  PubMed  CAS  Google Scholar 

  • Heathcote, J., Keeffe, E.B., Lee, S.S., Feinman, S.V., Tang, M.J., Reddy, K.R., Albert, D.G., Witt, K., Blatt, L.M. (1998). The consensus interferon study group. Retreatment of chronic hepatitis C with consensus interferon. Hepatology 27: 1136–1143.

    Article  PubMed  CAS  Google Scholar 

  • Hemmi, S., Bohni, R., Stark, G., Di-Marco, F., Aguet, M. (1994). A novel member of the interferon receptor family complements functionally of the murine interferon gamma receptor in human cells. Cell, 76: 803–810.

    Article  PubMed  CAS  Google Scholar 

  • Hoffmann, W.P., Zeuzem, S., Sarrazin, C. (2005). Hepatitis C virus-related resistance mechanisms to interferon alpha-based antiviral therapy. Journal of Clinical Virology, 32: 86–91.

    Article  CAS  Google Scholar 

  • Hoofnagle, J.H. (2004). Hepatocellular carcinoma: summary and recommendation. Gastroenterology, 127: S319–S323.

    Article  PubMed  Google Scholar 

  • Hoofnagle, J.H. (2002). Course and outcome of hepatitis C. Hepatology, 36: S21–29.

    Article  PubMed  Google Scholar 

  • Ji, H., Fraser, C.S., Yu, Y., Leary, J., Douda, J.A. (2004). Coordinated assembly of human translation initiation complexes by the hepatitis C virus internal ribosome entry site RNA. Proceedings of National Academy of Sciences (USA), 101: 16990–16995.

    Article  CAS  Google Scholar 

  • Kalkeri, G., Khalap, N., Garry, R., Fermin, C., Dash, S. (2001). Hepatitis C viral protein affect cell viability and membrane permeability. Experimental and Molecular Pathology, 71: 194–208.

    Article  PubMed  CAS  Google Scholar 

  • Karin, M., Lawrence, T., Nizet, V. (2006). Innate immunity gone awry: linking microbial infections to chronic inflammation and cancer. Cell, 124: 823–835.

    Article  PubMed  CAS  Google Scholar 

  • Kato, T., Date, T., Miyamoto, M., Sugiyama, M., Tanaka, Y., Orito, E., Ohno, T., Sugihara, K., Hasegawa, I., Fujiwara, K., Ito, K., Ozasa, A., Mizokami, M., Wakita, T. (2005). Detection of anti-hepatitis C virus effect of interferon and ribavirin by a sensitive replicon system. Journal of Clinical Microbiology, 43: 5679–5684.

    Article  PubMed  CAS  Google Scholar 

  • Kato, J., Kato, N., Moriyama, M., Goto, T., Taniguchi, H., Shiratori, Y., Omata, M. (2002). Interferons specifically suppress the translation from the internal ribosome entry site of hepatitis C virus through a double-stranded RNA- activated protein kinase-independent pathway. Journal of Infectious Disease, 186: 155–163.

    Article  CAS  Google Scholar 

  • Katze, M.G., He, Y., Gale, M. (2002). Viruses and interferon: a fight for supremacy. Nature Review, 675–687.

    Google Scholar 

  • Kawai, T., Akira, S. (2006). Innate immune recognition of viral infection. Nature Immunology, 7: 131–137.

    Article  PubMed  CAS  Google Scholar 

  • Keskinen, P., Melen, K., Julkunen, I (2002). Expression of HCV structural proteins impairs IFN-mediated antiviral response. Virology, 299: 164–171.

    Article  PubMed  CAS  Google Scholar 

  • Khaber, K.S.A., Al-Zoghaibi, F., Al-Ahdal, M.N., Murayama, T., Dhalla, M., Mukaida, N., Taha, M., Al-Sedairy, S.T., Siddiqui, Y., Kessie, G., Matsushima, K. (1997). The alpha chemokine, interleukin 8 inhibits the antiviral action of interferon alpha. Journal of Experimental Medicine, 186: 1077–1085.

    Article  Google Scholar 

  • Kiyosawa, K., Umemura, T., Ichigo, T., Matsumoto, A., Yoshizawa, K., Tanaka, E. (2004). Hepatocellular carcinoma recent trends in Japan. Gastroenterology, 127 (Suppl.): 17–26.

    Google Scholar 

  • Koev, G., Duncan, R.F., Lai, M.M. (2002). Hepatitis C virus IRES-dependent translation is insensitive to an eIF2alpha-independent mechanism of inhibition by interferon in hepatocyte cell lines. Virology, 297: 195–202.

    Article  PubMed  CAS  Google Scholar 

  • Kolykhalov, A.A., Agapov, E.V., Blight, K.J., Mihalik, K., Feinstone, S.M., Rice, C.M. (1997). Transmission of hepatitis C by intrahepatic inoculation with transcribed RNA. Science, 277: 570–574.

    Article  PubMed  CAS  Google Scholar 

  • Landolfo, S., Gribaudo, G., Angeretti, A., Gariglio, M. (1995). Mechanisms of viral inhibition by interferons. Pharmacological Therapy, 65: 415–442.

    Article  CAS  Google Scholar 

  • Langland, J.O., Cameron, J.M., Heck, M.C., Jancovich, J.K., Jacob, B.L. (2006). Inhibition of PKR by RNA and DNA viruses. Virus Research, 119: 100–110.

    Article  PubMed  CAS  Google Scholar 

  • Li, K., Foy, E., Ferreon, J.C., Nakamura, M., Ferreon, A.C.M., Ikeda, M., Ray, S.C., Gale, M., Lemon, S.M. (2005). Immune evasion by hepatitis C virus NS3/4A protease-mediated cleavage of the toll-like receptor 3 adapter protein TRIF. Proceedings of National Academy of Sciences (USA), 102: 2992–2997.

    Article  CAS  Google Scholar 

  • Lin, W., Choe, W.H., Hiasa, Y., Kamegaya, Y., Blackard, J.T., Schmidt, E.V., Chung, R.T. (2005). Hepatitis C virus expression suppresses interferon signaling by degrading STAT1. Gastroenterology, 128: 1034–1041.

    Article  PubMed  CAS  Google Scholar 

  • Lindenbach, B.D., Evans, M.J., Syder, A.J., Wolk, B., Tellinghuisen, T.L., Liu, C.C., Maruyama, T., Hynes, R.O., Burton, D.R., McKeating, J.A., Rice, C.M. (2005). Complete replication of hepatitis C virus in cell culture. Science, 309: 623–626.

    Article  PubMed  CAS  Google Scholar 

  • Lohmann, V., Korner, F., Koch, J.O., Herian, U., Theilmann, L., Bartenschlager, R. (1999). Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line. Science, 285: 110–113.

    Article  PubMed  CAS  Google Scholar 

  • Lucas, S., Bartolome, J., Correno, V. (2005). Hepatitis C virus core protein down–regulates transcription of interferon-induced antiviral genes. Journal of Infectious Disease, 191: 93–99.

    Article  Google Scholar 

  • Manns, M.P., McHutchison, J.G., Gordon, S.C., Rustgi, V.K., Shiffman, M., Reindollar, R., Goodman, Z.D., Koury K, Ling, M., Albrecht, J.K., the International Hepatitis Interventional Therapy Group. (2001). Peginterferon alpha-2b plus ribavirin compared with interferon alpha 2b plus ribavirin for initial treatment of chronic hepatitis C. A randomized trial. Lancet, 358: 958–965.

    Article  PubMed  CAS  Google Scholar 

  • Macquillan, G.C., Niu, X., Speers, D., English, S., Garas, G., Harnett, G.B., Reed, W.D., Allam, J.E., Jeffrey, G.P. (2004). Does sequencing the PKRBD of hepatitis C virus NS5A predict therapeutic response to combination therapy in an Australian population? Journal of Gastroenterology Hepatology, 19: 551–557.

    Article  CAS  Google Scholar 

  • Meng, L.R., Mohan, R., Kwok, B.H., Elofsson, M., Sin, N., Crew, C.M. (1999). Epoxomicin, a potent & selective proteosome inhibitor, exhibits in vivo antiinflammatory activity. Proceedings of National Academy of Science (USA), 96: 10403–10408.

    Article  CAS  Google Scholar 

  • Miyamoto, M., Kato, T., Date, T., Mizokami, M., Wakita, T. (2006). Comparison between subgenomic replicons of hepatitis C virus genotypes 2a (JFH-1) and 1b (Con-1 NK 5.1). Intervirology, 49: 37–43.

    Article  PubMed  CAS  Google Scholar 

  • Nousbaum, J., Polyak, S.J., Ray, S.C., Sullivan, D.G., Larson, A.M., Carithers, R.L., Gretch, D.R. (2000). Prospective characterization of full-length hepatitis C virus NS5A quasispecies during induction and combination antiviral therapy. Journal of Virology, 74: 9028–9038.

    Article  PubMed  CAS  Google Scholar 

  • Novick, D., Cohen, B., Bubinstein, M. (1994). The human interferon alpha/beta receptor: characterization and molecular cloning. Cell, 77: 391–400.

    Article  PubMed  CAS  Google Scholar 

  • Otto, G.A., Pulglisi, J.D. (2004). The pathway of HCV IRES-mediated translation initiation. Cell, 119: 369–380.

    Article  PubMed  CAS  Google Scholar 

  • Pai, M., Prabhu, R., Panebra, A., Nangle, S., Haque, S., Bastian, F., Garry, R., Agrawal, K., Goodbourn, S., Dash, S. (2005). Activation of interferon stimulated response element (ISRE) in Huh-7 cells replicating HCV subgenomic RNA. Intervirology, 48: 301–311.

    Article  PubMed  CAS  Google Scholar 

  • Paterson, M., Laxton, C.D., Thomas, H.C., Ackril, A.M., Foster, G.R. (1999). Hepatitis C virus NS5A protein inhibits interferon antiviral activity, but the effects do not correlate with clinical response. Gastroenterology, 117: 1187–1197.

    Article  PubMed  CAS  Google Scholar 

  • Pawlotsky, J.M. (2000). Hepatitis C virus resistance to antiviral therapy. Hepatology, 32: 889–896.

    Article  PubMed  CAS  Google Scholar 

  • Pawlotsky, J.M. (2003). The nature of interferon-alpha resistance in hepatitis C virus infection. Current Opinion on Infectious Disease, 16: 587–592.

    Article  CAS  Google Scholar 

  • Pesch, V., Lanaya, H., Renauld, J.C., Michiels, T. (2004). Characterization of the murine alpha interferon gene family. Journal of Virology, 78: 8219–8228.

    Article  PubMed  CAS  Google Scholar 

  • Peterson, M., Laxton, C.D., Thomas, H.C., Ackrill, A.M., Foster, G.R. (1999). Hepatitis C virus NS5A protein inhibits interferon antiviral activity but the effects do not correlate with clinical response. Gastroenterology, 117: 1187–1197.

    Article  Google Scholar 

  • Platanias, L.C., Uddin, S., Domanski, P., Colamonici, O.R. (1996). Differences in interferon alfa and beta signalling. Interferon beta selectively induces the interaction of the alpha and beta L subunits of the type 1 interferon receptor. Journal of Biological Chemistry, 271: 23630–23633.

    Article  PubMed  CAS  Google Scholar 

  • Polyak, S.J., Khabar, K.S.A., Rezeiq, M., Gretch, D.R. (2001). Elevated levels of interleukin-8 in serum are associated with hepatitis C virus infection and resistance to interferon therapy. Journal of Virology, 75: 6209–6211.

    Article  PubMed  CAS  Google Scholar 

  • Polyak, S.J., Khabar, K.S.A., Paschal, D.M., Ezelle, H.J., Duverlie, G., Barber, G.N., Levy, D.E., Mukaida, N., Gretch, D.R. (2001). Hepatitis C virus nonstructural 5A protein induces interleukin-8 leading to partial inhibition of the interferon induced antiviral response. Journal of Virology, 75: 6095–6106.

    Article  PubMed  CAS  Google Scholar 

  • Prabhu, R., Joshi, V., Garry, R.F., Bastian, F., Haque, S., Regenstein, F., Thung, S.N., Dash, S. (2004). Interferon alpha-2b inhibits negative strand RNA and protein expression from full-length HCV1a infectious clone. Experimental and Molecular Pathology, 76: 242–252.

    Article  PubMed  CAS  Google Scholar 

  • Qi, Z., Kalkeri, G., Hanible, J., Prabhu, R., Bastian, F., Garry, R.F., Dash, S. (2003). Stem-loop structures (II-IV) of the 5′ untranslated sequences are required for the expression of the full-length hepatitis C virus genome. Archives of Virology, 148: 449–467.

    Article  PubMed  CAS  Google Scholar 

  • Reed, K.E., Rice, C.M. (2000). Overview of hepatitis C virus genome structure, polyprotein processing and protein properties. Current Topics of Microbiology & Immunology, 242: 55–84.

    CAS  Google Scholar 

  • Rice, C.M. (1996). Flaviviridae: the viruses and their replication. In: B.N. Fields, D.M. Knipe, P.M. Howley, et al. (eds). (pp. 936–959) Fields Virology, 3rd ed., Philadelphia: Lippincott-Raven.

    Google Scholar 

  • Rivas-Estilla, A.M., Svitkin, Y., Lastra, M.L., Hatzoglou, M., Sherker, A., Koromilas, A.E. (2002). PKR-dependent mechanisms of gene expression from a subgenomic hepatitis C virus clone. Journal of Virology, 76: 10637–10653.

    Article  PubMed  CAS  Google Scholar 

  • Robek, M.D., Boyd, B.S., Chisari, F.V. (2005). Lambda interferon inhibits hepatitis B and hepatitis C virus replication. Journal of Virology, 79: 3851–3854.

    Article  PubMed  CAS  Google Scholar 

  • Schinkel, J., Spoon, W.J., Kroes, A.C. (2004). Meta-analysis of mutations in the NS5A gene and hepatitis C virus resistance to interferon therapy: uniting discordant conclusions. Antiviral Therapy, 9: 275–286.

    PubMed  CAS  Google Scholar 

  • Schroder, K., Hertzog, P.J., Ravasi, T., Hume, D.A. (2004). Interferon gamma: an overview of signals, mechanisms and functions. Journal of Leukocyte Biology, 75: 163–189.

    Article  PubMed  CAS  Google Scholar 

  • Sen, G.C. (2001). Viruses and interferons. Annual Revew of Microbiology, 55: 255–281.

    Article  CAS  Google Scholar 

  • Shimazaki, T., Honda, M., Kaneko, S., Kobayashi, K. (2002). Inhibition of internal ribosomal entry site-directed translation of HCV by recombinant IFN-alpha correlates with a reduced La protein. Hepatology, 35: 199–208.

    Article  PubMed  CAS  Google Scholar 

  • Shimizu, Y.K., Feinstone, S.M., Kohara, M., Purcell, R.H., Yoshikura, H. (1996). Hepatitis C virus: detection of intracellular virus particles by electron microscopy. Hepatology, 23: 205–209.

    Article  PubMed  CAS  Google Scholar 

  • Shimizu, Y.K., Purcell, R.H., Yoshikura, H. (1993). Correlation between the infectivity of hepatitis C virus in vivo and its infectivity in vitro. Proceedings of National Academy of Sciences (USA), 90: 6037–6041.

    Article  CAS  Google Scholar 

  • Shimizu, Y.K., Iwamoto, A., Hijikata, M., Purcell, R.H., Yoshikura, H. (1992). Evidence for in vitro replication of hepatitis C virus genome in a human T-cell line. Proceedings of National Academy of Sciences (USA), 89: 5477–5481.

    Article  CAS  Google Scholar 

  • Shimizu, Y.K., Yoshikura, H. (1994). Multicycle infection of hepatitis C virus in cell culture and inhibition by alpha and beta interferons. Journal of Virology, 68: 8406–8408.

    PubMed  CAS  Google Scholar 

  • Simmonds, P. (2004). Genetic diversity and evolution of hepatitis C virus—15 years on. Journal of General Virology, 85: 3173–3188.

    Article  PubMed  CAS  Google Scholar 

  • Stark, G.R., Kerr, I.M., William, B.R.G., Silverman, R.H., Schreiber, R.D. (1998). How cells respond to interferons. Annual Review of Biochemistry, 67: 227–264.

    Article  PubMed  CAS  Google Scholar 

  • Strader, D.B., Wright, T., Thomas, D.L., Seeff, L.B. (2004). Diagnosis, management, and treatment of hepatitis C. Hepatology, 39: 1147–1171.

    Article  PubMed  Google Scholar 

  • Sumpter, R., Loo, Y.-M., Foy, E., Li, K., Yoneyama, M., Fujita, T., Lemon, S.M., Gale, M. (2005). Regulating intracellular antiviral defense and permissiveness to hepatitis C virus RNA replication through a cellular RNA helicase, RIG-I. Journal of Virology, 79: 2689–2699.

    Article  PubMed  CAS  Google Scholar 

  • Taylor, D.R., Shi, S.T., Romano, P.R., Barber, G.N., Lai, M.C. (1999). Inhibition of the interferon-inducible protein kinase R by HCV E2 protein. Science, 285: 107–109.

    Article  PubMed  CAS  Google Scholar 

  • Uze, G., Lutfalla, G., Gresser, I. (1990). Genetic transfer of a functional human interferon alpha-receptor into mouse cells: cloning and expression of its cDNA. Cell, 60: 225–234.

    Article  PubMed  CAS  Google Scholar 

  • Uze, G., Lutfalla, G., Mongensen, K.E. (1995). Alpha and beta interferons and their receptor and their friends and relations. Journal of Interferon Research, 15: 3–26.

    Article  CAS  Google Scholar 

  • Vrolijk, J.M., Kaul, A., Hanson, B.E., Lohmann, V., Haagmans, B.L., Schalm, S.W., Bartenschalager, R. (2003). A replicon-based bioassay for the measurement of interferons in patients with chronic hepatitis C. Journal of Virological Methods, 110: 201–209.

    Article  PubMed  CAS  Google Scholar 

  • Wakita, T., Pietschmann, T., Kato, T., Date, T., Miyamoto, M., Zhao, Z., Murthy, K., Habermann, A., Krausslich, H.G., Mizokami, M., Bartenschlager, R., Liang, T.J. (2005). Production of infectious hepatitis C virus in tissue culture from cloned viral genome. Nature Medicine, 11: 791–796.

    Article  PubMed  CAS  Google Scholar 

  • Wang, C., Pflugheber, J., Sumpter, R., Sodora, D.L., Hui, D., Sen, G., Gale, M. (2003). Alpha interferon induces distinct translational control programs to suppress hepatitis C virus RNA replication. Journal of Virology, 77: 3898–3912.

    Article  PubMed  CAS  Google Scholar 

  • William, B.R.G. (1991). Transcriptional regulation of interferon stimulated genes. European Journal of Biochemistry, 200: 1–11.

    Article  Google Scholar 

  • Yanagi, M., Purcell, R.H., Emerson, S.U., Bukh, J. (1997). Transcripts from a single full-length cDNA clone of hepatitis C virus are infectious when directly transfected in to the livers of a chimpanzee. Proceedings of National Academy of Sciences (USA), 94: 8738–8743.

    Google Scholar 

  • Yi, M., Lemon, S.M. (2003). 3′ non-translated RNA signals required for replication of hepatitis C virus RNA. Journal of Virology, 77: 3557–3568.

    Article  PubMed  CAS  Google Scholar 

  • Yoo, B.J., Selby, M.J., Choe, J., Suh, B.S., Choi, S.H, Joh, J.S., Nuovo, G.J., Lee, H.-S. Houghton, M., Han, J.H. (1995). Transfection of a differentiated human hepatoma cell line (Huh-7) with in vitro-transcribed hepatitis C virus (HCV) RNA and establishment of a long-term culture persistently infected with HCV. Journal of Virology, 69: 32–38.

    PubMed  CAS  Google Scholar 

  • Zhong, J., Gastaminza, P., Cheng, G., Kapadia, S., Kato, T., Burton, D.R., Wieland, S.F., Uprichard, S.L., Wakita, T., Chisari, F.V. (2005). Robust hepatitis C virus infection in vitro. Proceedings of National Academy of Sciences (USA), 102: 9294–9299.

    Google Scholar 

  • Zhu, H., Zhao, H., Collins, C.D., Eckenrode, S.E., Run, Q., McIndoe, R.A., Crawford, J.M., Nelson, D.R., She, J.-X., Liu, C. (2003). Gene expression associated with interferon alpha antiviral activity in an HCV replicon cell line. Hepatology, 37: 1180–1188.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pathology and Laboratory Medicine, Tulane University Health Sciences Center, 1430 Tulane Avenue, SL 79, New Orleans, LA 70112

    Srikanta Dash Ph.D (Associate Professor)

Authors
  1. Srikanta Dash Ph.D
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Sidhartha Hazari
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Robert F Garry
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Fredric Regenstein
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. University of Bari and National Institute for Digestive Disease, Castellana Grotte, Bari, Italy

    Emilio Jirillo

Rights and permissions

Reprints and permissions

Copyright information

© 2008 Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Dash, S., Hazari, S., Garry, R.F., Regenstein, F. (2008). Mechanisms of Interferon Action and Resistance in Chronic Hepatitis C Virus Infection: Lessons Learned from Cell Culture Studies. In: Jirillo, E. (eds) Hepatitis C Virus Disease. Springer, New York, NY. https://doi.org/10.1007/978-0-387-71376-2_2

Download citation

Publish with us

Policies and ethics

Search

Navigation